tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ocugen’s Strategic Moves and Financial Projections Justify Buy Rating
PremiumRatingsOcugen’s Strategic Moves and Financial Projections Justify Buy Rating
24d ago
Ocugen Announces Merger with Carisma Therapeutics
Premium
Company Announcements
Ocugen Announces Merger with Carisma Therapeutics
25d ago
Carisma Therapeutics, OrthoCellix enter definitive merger agreement
Premium
The Fly
Carisma Therapeutics, OrthoCellix enter definitive merger agreement
25d ago
Ocugen’s Promising Future: Buy Rating Backed by Strategic Licensing and Growth Plans
PremiumRatingsOcugen’s Promising Future: Buy Rating Backed by Strategic Licensing and Growth Plans
1M ago
Ocugen Signs License Agreement for OCU400 in Korea
Premium
Company Announcements
Ocugen Signs License Agreement for OCU400 in Korea
1M ago
Ocugen announcing signing of term sheet, enter licensing agreement for OCU400
Premium
The Fly
Ocugen announcing signing of term sheet, enter licensing agreement for OCU400
1M ago
Ocugen Inc’s Earnings Call: Optimism Amid Financial Challenges
PremiumCompany AnnouncementsOcugen Inc’s Earnings Call: Optimism Amid Financial Challenges
2M ago
Ocugen reports Q1 EPS (5c), consensus (6c)
Premium
The Fly
Ocugen reports Q1 EPS (5c), consensus (6c)
2M ago
Ocugen to Present at Eyecelerator Conference May 2025
Premium
Company Announcements
Ocugen to Present at Eyecelerator Conference May 2025
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100